Bacteriophages: A Challenge for Antimicrobial Therapy
Microorganisms · 07.01.2025 · 13 (1) · 100
DOI: 10.3390/microorganisms13010100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 07.01.2025. Verfasst von Nallelyt Segundo-Arizmendi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Microbiología y Parasitología, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Phage therapy, which involves the use of bacteriophages (phages) to combat bacterial infections, is emerging as a promising approach to address the escalating threat posed by multidrug-resistant (MDR) bacteria. This brief review examines the historical background and recent advancements in phage research, focusing on their genomics, interactions with host bacteria, and progress in medical and biotechnological applications. Additionally, we expose key aspects of the mechanisms of action, and therapeutic uses of phage considerations in treating MDR bacterial infections are discussed, particularly in the context of infections related to virus–bacteria interactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratorio de Microbiología y Parasitología, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
- Laboratorio de Biología Computacional y Virómica Integrativa, Centro de Investigación en Dinámica Celular, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
- Laboratorio de Estudios Ecogenómicos, Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
- Laboratorio 1 de Tecnología Farmacéutica, Facultad de Farmacia de la, Universidad Autónoma del Estado de Morelos, Cuernavaca 62209, Mexico.
ORCID-Profile: Nallelyt Segundo-Arizmendi, Abraham Rivera-Ramírez, Gamaliel López-Leal, Efren Hernández-Baltazar
Zitieren
APA
Segundo-Arizmendi, N., Arellano-Maciel, D., Rivera-Ramírez, A., Piña-González, A. M., López-Leal, G., & Hernández-Baltazar, E. (2025). Bacteriophages: A Challenge for Antimicrobial Therapy. Microorganisms, 13(1), 100. https://doi.org/10.3390/microorganisms13010100
Vancouver
Segundo-Arizmendi N, Arellano-Maciel D, Rivera-Ramírez A, Piña-González AM, López-Leal G, Hernández-Baltazar E. Bacteriophages: A Challenge for Antimicrobial Therapy. Microorganisms. 2025;13(1):100. doi:10.3390/microorganisms13010100
BibTeX
@article{SegundoArizmendi2025,
author = {Segundo-Arizmendi, Nallelyt and Arellano-Maciel, Dafne and Rivera-Ramírez, Abraham and Piña-González, Adán Manuel and López-Leal, Gamaliel and Hernández-Baltazar, Efren},
title = {Bacteriophages: A Challenge for Antimicrobial Therapy},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {1},
pages = {100},
doi = {10.3390/microorganisms13010100}
}
EUVIMED